What is the optimal dosing schedule and duration of zoledronic acid in breast cancer patients with bone metastases?

The short answer is YES, a monthly schedule x 1 year, followed by a dose every 3 months seems to be a reasonable standard of care. However, additional research is needed to answer the question about optimal duration of therapy and dose/schedule in years beyond the first two years of therapy.